Cheryl Willman was named executive director of Mayo Clinic Cancer Programs and director of Mayo Clinic Comprehensive Cancer Center. Her transition to Mayo will occur sometime in August, officials said.
40-04 FDA News
YOU MAY BE INTERESTED IN
Small dreams have no power to move hearts, and in a new six-year strategic plan, St. Jude Children’s Research Hospital is thinking very big. What would it take to drastically increase cure rates for childhood cancer worldwide?
Clinical trials for oncology drugs are running into unique challenges as protocols become more complex and as the number of new investigational agents continues to outpace all other drugs, according to a recent study by Tufts University researchers.
Gynecologic oncologist Sarah Temkin has observed and experienced sexism in many venues: in hospital inpatient units, in the clinic infusion site, in the emergency room, but nothing is more blatant than sexism in the operating room.
The story of modern cancer therapy would not be complete without the inclusion of the work of Paul Calabresi and some insights about the challenges he faced, along with his accomplishments.
Becky Stephens is more than willing to go to great lengths for a miracle. With a diagnosis of stage 4 colon cancer and chemo treatments that weren’t working, she was desperate for hope—and found it in a clinical trial.